Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
about
HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activityEfficacy of Carraguard-based microbicides in vivo despite variable in vitro activityLactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN--gp120 interactionHow do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?Microbicides: a new hope for HIV preventionVaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protectionRecent Insights into the HIV/AIDS Pandemic.Peptide and protein-based inhibitors of HIV-1 co-receptorsMicrobicides and other topical agents in the prevention of HIV and sexually transmitted infections.SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeysMucosal transmission of human immunodeficiency virusThe HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future?DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4.HIV binding, penetration, and primary infection in human cervicovaginal tissueHuman immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains.Improving defences at the portal of HIV entry: mucosal and innate immunity.The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry.Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure.Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env.HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talkLocalized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epitheliumPolyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infectionMucosal immunology of the genital and gastrointestinal tracts and HIV-1 infectionHigh Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells.Development of topical microbicides to prevent the sexual transmission of HIVPPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infectionR5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models.HSV type 2 infection increases HIV DNA detection in vaginal tissue of mice expressing human CD4 and CCR5Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routes.Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytesHIV-1 Transmission, Replication Fitness and Disease Progression.Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.Viral dynamics during primary simian immunodeficiency virus infection: effect of time-dependent virus infectivity.Wide variation in the multiplicity of HIV-1 infection among injection drug usersThe nonnucleoside reverse transcriptase inhibitor UC-781 inhibits human immunodeficiency virus type 1 infection of human cervical tissue and dissemination by migratory cellsDetection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection.Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture.
P2860
Q21076115-699D06AC-C8B7-4223-898D-B0162B16FB07Q21562543-57246D9E-A745-4607-9F2C-58623F524061Q24556674-FCA06164-E340-4A14-90AB-6DE45F784699Q25257230-3D762BAF-522A-4CB0-AD5E-3692DD2C985FQ27022779-0752F3EC-4489-42A8-B1CD-BD34DDB69615Q27332360-1ABC4057-543E-4CAD-94FC-AAEB870F814DQ30235024-95090DCD-F6C1-4B98-9AD3-2B6F7D8DF6BBQ30352117-7EFAC0D6-20BC-4FDC-9329-18BEEB6C25A5Q30359545-6F1FB691-2AC5-4844-B168-15605D6062ADQ30372757-29E2E374-CD0A-48EA-BE27-7B96668C5ABCQ30412036-4463DB6E-0165-40EB-A328-1BC53EDDDBF6Q30431054-FA9D4D82-0516-4AEA-A661-8D7C778E3597Q30472149-292E20DA-215B-42E8-94E1-1C54035A2F67Q30476070-AFD82B74-90D0-47BC-A2AE-9A48912FBF1AQ30480954-C245499D-F27E-4D76-B6FA-94DE6EA0F6C3Q30494738-5C5ADD84-4FEC-4350-8211-24EA1F778C69Q33252188-24A3A8D9-E8FB-44AE-872A-810A46A875B1Q33354076-4BCA3F0B-C23D-4E7F-ABB7-EA213B7A30E2Q33372270-D5ED386E-3DAA-4D11-8D85-616F65BDD9F7Q33381657-62B28FF0-1690-433D-86BB-FBD90EA46643Q33397378-0A430470-DD4F-48D7-B584-78E291683EC0Q33479167-07FB044E-46CE-44B5-B409-BC39B1A29601Q33575368-51D07B72-C33A-4782-B1D6-FD7523087B3AQ33582135-042F9EB1-8545-4166-A2E9-99944510539CQ33591038-0E1F29F3-0A80-47CB-9C52-B20FCC1A93EFQ33625073-08246E3E-8D51-4003-9405-2564AAF361DBQ33628817-BD87DF5F-17F8-4748-967F-547FC56FA55DQ33640144-F684746C-75F7-4264-A676-79CEBC3B341DQ33680806-8BD48709-2F76-4AA7-BB66-D8787112D51AQ33729355-5768C23A-38B6-4C6E-8DFA-FDB409B4AF30Q33755099-846A6F1F-888A-42E2-A092-2E358C2F6898Q33758570-F7074A5C-EA73-4581-A55A-AE8A3257F794Q33780450-A832A0E6-44D6-4B7B-AB6F-6A8DED3BC9E6Q33826587-74B8B4DA-E227-484B-AEF4-7607424B8548Q33877419-4AAF84CD-F4DC-48E1-89B8-2FC95CCCDC80Q33930525-0810520F-D83F-43CA-BA04-096D338C94BBQ33954795-64E39D07-42B5-446C-9295-929227E0B908Q33962742-98ED3B13-B5B5-483D-B650-3887205CE22FQ33966586-780E837F-E38B-415B-9BD2-53DD3C1AF32AQ33983315-4F947B45-9F0E-43A6-900D-770530D7091C
P2860
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@ast
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@en
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@en-gb
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@nl
type
label
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@ast
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@en
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@en-gb
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@nl
prefLabel
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@ast
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@en
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@en-gb
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@nl
P3181
P356
P1433
P1476
Transmission, acute HIV-1 infection and the quest for strategies to prevent infection
@en
P2093
Ashley T Haase
Melissa Pope
P2888
P304
P3181
P356
10.1038/NM0703-847
P407
P577
2003-07-01T00:00:00Z
P5875
P6179
1038384783